Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2 positive metastatic breast cancer Post date 16 March 2026 ← New and emerging treatments for anxiety disorders → “I witnessed endless suffering”—the GP whose journey into medicine started in a refugee camp